Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000721748-13-000192
Filing Date
2013-05-20
Accepted
2013-05-20 16:52:44
Documents
7
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A f10ka_andain.htm 10-K/A 20162
  Complete submission text file 0000721748-13-000192.txt   3665903

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE andne-20121231.xml EX-101.INS 582228
3 XBRL SCHEMA FILE andne-20121231.xsd EX-101.SCH 41504
4 XBRL CALCULATION FILE andne-20121231_cal.xml EX-101.CAL 56264
5 XBRL DEFINITION FILE andne-20121231_def.xml EX-101.DEF 137445
6 XBRL LABEL FILE andne-20121231_lab.xml EX-101.LAB 262472
7 XBRL PRESENTATION FILE andne-20121231_pre.xml EX-101.PRE 230629
Mailing Address 350 S. CENTER STREET SUITE 500 RENO NV 89501
Business Address 350 S. CENTER STREET SUITE 500 RENO NV 89501 775-333-5997
ANDAIN, INC. (Filer) CIK: 0001321502 (see all company filings)

EIN.: 202066406 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51216 | Film No.: 13858989
SIC: 2834 Pharmaceutical Preparations